151. Proteomic Approaches for Urine Biomarker Discovery in Bladder Cancer
- Author
-
Ming-Hui Yang and Yu-Chang Tyan
- Subjects
Pathology ,medicine.medical_specialty ,Bladder cancer ,Proteinuria ,business.industry ,Urinary system ,Urine ,urologic and male genital diseases ,Proteomics ,medicine.disease ,female genital diseases and pregnancy complications ,Albuminuria ,Biomarker (medicine) ,Medicine ,medicine.symptom ,Biomarker discovery ,business - Abstract
Bladder cancer is the most common urological cancer with higher incidence rate in the endemic areas of blackfoot disease (BFD) in southern Taiwan. Urine, a blood filtrate produced by the urinary system, is readily collected and is an important source of information for bladder cancers because it is directly exposed to bladder epithelium. Global analysis of the human urinary proteome is important for understanding urinary tract diseases. The aim of this chapter was to utilize the proteomic approach to establish urinary protein patterns of bladder cancer. The experimental results showed that most patients with bladder cancer had proteinuria or albuminuria. In the proteomic analysis, the urinary proteome was identified by nano-high-performance liquid chromatography electrospray ionization tandem mass spectrometry (nano-HPLC-ESI-MS/MS) followed by peptide fragmentation pattern analysis. ADAM28, identified by proteomic approaches and confirmed by ELISA, showed significant differences compared with normal individuals. The upregulation of urinary ADAM28 in bladder cancer was revealed, so it may be a biomarker of bladder cancer.
- Published
- 2012
- Full Text
- View/download PDF